We are live on ! Find out more
CLB icon

Core Laboratories

344 hedge funds and large institutions have $5.98B invested in Core Laboratories in 2014 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 131 increasing their positions, 113 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more repeat investments, than reductions

Existing positions increased: 131 | Existing positions reduced: 113

2.79% more ownership

Funds ownership: 88.94%91.73% (+2.8%)

7% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 41

1% less funds holding

Funds holding: 346344 (-2)

10% less capital invested

Capital invested by funds: $6.61B → $5.98B (-$633M)

13% less funds holding in top 10

Funds holding in top 10: 87 (-1)

45% less call options, than puts

Call options by funds: $34.4M | Put options by funds: $62.3M

Holders
344
Holders Change
-2
Holders Change %
-0.58%
% of All Funds
9.98%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.2%
New
44
Increased
131
Reduced
113
Closed
41
Calls
$34.4M
Puts
$62.3M
Net Calls
-$27.9M
Net Calls Change
-$4.15M
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
76
Citigroup
New York
$11.6M -$111K -716 -0.9%
JMPWA
77
JP Morgan Private Wealth Advisors
California
$11.5M +$3.74M +24,261 +45%
U
78
UBS
Switzerland
$11.4M +$3.6M +23,312 +43%
ACH
79
ArrowMark Colorado Holdings
Colorado
$11.2M +$2.05M +13,260 +21%
BNP Paribas Asset Management
80
BNP Paribas Asset Management
France
$11M -$4.89M -31,704 -30%
ACM
81
Atlanta Capital Management
Georgia
$10.8M +$5.94M +38,475 +109%
DCLA
82
Douglas C. Lane & Associates
New York
$9.75M +$6.22M +40,292 +153%
SRC
83
Shufro Rose & Co
New York
$9.74M +$1.78M +11,505 +21%
TAM
84
Tocqueville Asset Management
New York
$9.7M -$154K -1,000 -1%
CHAM
85
Clear Harbor Asset Management
Connecticut
$9.65M -$6.17K -40 -0.1%
CS
86
Credit Suisse
Switzerland
$9.62M +$772K +4,999 +8%
GA
87
Geneva Advisors
Illinois
$9.58M -$3.41M -22,122 -25%
Charles Schwab
88
Charles Schwab
California
$9.57M +$376K +2,436 +4%
Dimensional Fund Advisors
89
Dimensional Fund Advisors
Texas
$9.41M +$15.4K +100 +0.2%
Barclays
90
Barclays
United Kingdom
$8.59M +$1.46M +9,443 +19%
AIM
91
Arcadia Investment Management
Michigan
$8.29M +$205K +1,325 +2%
Ameriprise
92
Ameriprise
Minnesota
$8.28M -$2.29M -14,817 -21%
TMAM
93
Tokio Marine Asset Management
Japan
$8.2M +$2.07M +13,400 +31%
APG Asset Management
94
APG Asset Management
Netherlands
$8.05M +$1.55M +10,061 +22%
LWCFA
95
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$7.58M -$68.7K -445 -0.9%
M&T Bank
96
M&T Bank
New York
$7.46M +$7.14M +46,243 +977%
BJ
97
BlackRock Japan
Japan
$7.45M +$797K +5,163 +11%
JP Morgan Chase
98
JP Morgan Chase
New York
$7.44M +$2.46M +15,957 +46%
Bank of America
99
Bank of America
North Carolina
$7.35M -$764K -4,948 -9%
Franklin Resources
100
Franklin Resources
California
$7.32M -$3.86M -25,000 -33%

CLB Hedge Fund Activity: Q3 2014 in Review

344 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q3 2014, worth a combined $5.98B — down 9.6% from $6.61B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new CLB positions and 41 closed out — a net gain of 3 holders — while 131 added to existing stakes and 113 trimmed.

The largest buyer was Russell Frank Company, adding an estimated $53.5M. The largest seller was Norges Bank, cutting an estimated $59.4M.

  • 344 institutional investors held Core Laboratories (CLB) as of Q3 2014, down from 346 in Q2 2014.
  • Funds reported $5.98B of Core Laboratories stock for Q3 2014, down 9.6% quarter-over-quarter.
  • 44 funds opened new Core Laboratories positions in Q3 2014 and 41 closed out, a net change of +3 holders.
  • The largest Core Laboratories buyer in Q3 2014 was Russell Frank Company, an estimated $53.5M added.
  • The largest Core Laboratories seller in Q3 2014 was Norges Bank, an estimated $59.4M sold.

Based on aggregated 13F filings for Q3 2014.